ArticleTherapeutic advances in medical oncology2026
Cancer-derived inflammation is associated with bevacizumab resistance and inferior clinical outcomes in patients with metastatic colorectal cancer.
Ya-Nan Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.